Endometrial Neoplasms: all 1,347 studies

Page 6 of 14. Open to participants first (452), then studies with results posted, then the rest; newest registration first within each.

• Impact of Adjuvant Chemotherapy on the Quality of Life of Patients Treated for Stage II / III Endometrial CancerCompletedNCT03466788Not applicableResults posted
• Pilot Study to Assess the Potential Clinical Utility of 18F Fluciclovine PET for Cervical and Endometrial Cancer.TerminatedNCT03423082Phase 4Results posted
• A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or CarcinosarcomaCompletedNCT03395080Phase 2Results posted
• ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial CarcinomaCompletedNCT03394027Phase 2Results posted
• Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial CancerActive, not recruitingNCT03367741Phase 2Results posted
• Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.CompletedNCT03345485Phase 1/2Results posted
• A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid TumorsCompletedNCT03314935Phase 1/2Results posted
• Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial CancerCompletedNCT03300557Phase 2Results posted
• Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors.CompletedNCT03245736Phase 2Results posted
• A Study of Nivolumab in Selected Uterine Cancer PatientsCompletedNCT03241745Phase 2Results posted
• Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy?CompletedNCT03207126Not applicableResults posted
• Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue?CompletedNCT03207074Not applicableResults posted
• Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial CancerCompletedNCT03189446Phase 2Results posted
• Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic MalignanciesCompletedNCT03126110Phase 1/2Results posted
• VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial CancerActive, not recruitingNCT03120624Phase 1Results posted
• Single Agent ONC201 in Recurrent or Metastatic Endometrial CancerTerminatedNCT03099499Phase 2Results posted
• An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial CancerTerminatedNCT03077698Phase 2Results posted
• A Study of Durvalumab With or Without Tremelimumab in Endometrial CancerCompletedNCT03015129Phase 2Results posted
• Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid TumorsCompletedNCT02988817Phase 1/2Results posted
• Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial CancerActive, not recruitingNCT02912572Phase 2Results posted
• Positron Emission Tomography (PET) Imaging Studies With NIS ReporterTerminatedNCT02907073Phase 1/2Results posted
• Pembrolizumab in Ultramutated and Hypermutated Endometrial CancerCompletedNCT02899793Phase 2Results posted
• Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced MalignanciesCompletedNCT02807844Phase 1/2Results posted
• A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the UterusCompletedNCT02744898Phase 2Results posted
• A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic CancersCompletedNCT02728830Early Phase 1Results posted
• A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial CancerCompletedNCT02725268Phase 2Results posted
• Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial CancerCompletedNCT02684227Phase 2Results posted
• Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial CancerCompletedNCT02657928Phase 2Results posted
• MK-3475 Immunotherapy in Endometrial CarcinomaCompletedNCT02630823Phase 1Results posted
• Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid TumorsCompletedNCT02552121Phase 1/2Results posted
• Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial CancerCompletedNCT02549989Phase 2Results posted
• Pembro/Carbo/Taxol in Endometrial CancerCompletedNCT02549209Phase 2Results posted
• Preoperative Olaparib Endometrial Carcinoma Study (POLEN)CompletedNCT02506816Results posted
• Diet and Physical Activity in Uterine Cancer SurvivorsCompletedNCT02433080Not applicableResults posted
• Survivorship Promotion In Reducing IGF-1 TrialCompletedNCT02431676Phase 2Results posted
• Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)TerminatedNCT02393248Phase 1/2Results posted
• Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial CancerCompletedNCT02228681Phase 2Results posted
• A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node MappingCompletedNCT02209532Not applicableResults posted
• Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected CancersCompletedNCT02178722Phase 1/2Results posted
• Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICGCompletedNCT02068820Not applicableResults posted
• Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial CancerStatus unknownNCT02065687Phase 2/3Results posted
• Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical PatientsCompletedNCT02035787Phase 2Results posted
• Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic MalignanciesCompletedNCT02025985Phase 2Results posted
• Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid TumorsCompletedNCT02001623Phase 1/2Results posted
• Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer InvasionCompletedNCT01979003Early Phase 1Results posted
• Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing SurgeryTerminatedNCT01939028Not applicableResults posted
• Lymph Node Mapping in Patients With Endometrial CancerCompletedNCT01818739Not applicableResults posted
• A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial CarcinomaCompletedNCT01797523Phase 2Results posted
• Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial CancerCompletedNCT01767155Phase 3Results posted
• [F-18] Fluorothymidine PET/CT Imaging for Pelvic CancersCompletedNCT01717391Phase 2Results posted
• Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot StudyCompletedNCT01705288Early Phase 1Results posted
• An Endometrial Cancer Chemoprevention Study of MetforminCompletedNCT01697566Phase 3Results posted
• Determining the Sensitivity of Sentinel Lymph Nodes Identified With Robotic Fluorescence ImagingCompletedNCT01673022Not applicableResults posted
• Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical CancerCompletedNCT01672892Phase 3Results posted
• Robot Assisted Laparoscopic Hysterectomy vs. Abdominal Hysterectomy in Endometrial CancerCompletedNCT01526655Not applicableResults posted
• Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced AnaemiaCompletedNCT01444456Results posted
• A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial CancerTerminatedNCT01420081Phase 2Results posted
• A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial CancerCompletedNCT01379534Phase 2Results posted
• Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous CancerCompletedNCT01367002Phase 2Results posted
• Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial CancerCompletedNCT01307631Phase 2Results posted
• BKM120 as Second-line Therapy for Advanced Endometrial CancerCompletedNCT01289041Phase 2Results posted
• Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapyTerminatedNCT01251354Phase 2Results posted
• A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast CancersCompletedNCT01209195Phase 1Results posted
• Trisenox® in Women With Metastatic Endometrial CancerTerminatedNCT01184053Phase 2Results posted
• Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease ProgressionCompletedNCT01111461Phase 2Results posted
• Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological MalignanciesCompletedNCT01079832Phase 2Results posted
• Letrozole and RAD001 With Advanced or Recurrent Endometrial CancerActive, not recruitingNCT01068249Phase 2Results posted
• Feasibility Study Using the Xoft System for the Treatment of Endometrial CancerCompletedNCT01045187Not applicableResults posted
• Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial CancerTerminatedNCT01041027Phase 2Results posted
• Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial CancerCompletedNCT01005329Phase 2Results posted
• Letrozole as a Treatment of Endometrial CancerCompletedNCT00997373Not applicableResults posted
• Sleep and Endometrial CancerTerminatedNCT00936598Not applicableResults posted
• A Study of Patients Receiving High-Dose Rate BrachytherapyCompletedNCT00924027Phase 2Results posted
• The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial CancerCompletedNCT00910091Phase 2Results posted
• Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic ChemotherapyTerminatedNCT00900562Phase 2Results posted
• A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial CancerTerminatedNCT00883116Phase 3Results posted
• Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial CancerCompletedNCT00879359Phase 2Results posted
• Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial CancerCompletedNCT00729586Phase 2Results posted
• Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT00723255Phase 2Results posted
• Hysteroscopic Lymphatic Mapping for Endometrial CancerTerminatedNCT00671606Phase 2Results posted
• CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial CancerCompletedNCT00610740Phase 2Results posted
• Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological CancersCompletedNCT00545792Phase 2Results posted
• Vaginal Cuff Brachytherapy Followed by Chemotherapy in Patients With Endometrioid CancerCompletedNCT00542490Phase 2Results posted
• Papillary Serous Carcinoma of the EndometriumCompletedNCT00515073Phase 2Results posted
• Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial CarcinomaCompletedNCT00513786Phase 2Results posted
• Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol AcetateCompletedNCT00483327Phase 2Results posted
• Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial CancerTerminatedNCT00470067Phase 2Results posted
• VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT00462826Phase 2Results posted
• Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial CancerCompletedNCT00416455Phase 1/2Results posted
• Cetuximab in Patients With Progressive or Recurrent Endometrial CancerCompletedNCT00392769Phase 2Results posted
• Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial CancerCompletedNCT00388154Phase 2Results posted
• Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic CancerCompletedNCT00381888Phase 2Results posted
• A Trial for Patients With Advanced/Recurrent Endometrial CancerCompletedNCT00377520Phase 2Results posted
• Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.CompletedNCT00334295Phase 2Results posted
• Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By SurgeryCompletedNCT00331760Phase 2Results posted
• Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical CancersCompletedNCT00319748Phase 2Results posted
• Bevacizumab in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT00301964Phase 2Results posted
• Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial CancerCompletedNCT00267488Phase 2Results posted
• Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial CancerCompletedNCT00258362Phase 2Results posted
• Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for CancerCompletedNCT00245050Phase 3Results posted

← Endometrial Neoplasms overview